New knockout model confirms a role for androgen... : Hormones and Behavior (original) (raw)
ABSTRACT
Men are less likely than women to suffer from anxiety disorders. Because gonadal hormones play a crucial role in many behavioral sex differences, they may underlie sex differences in human anxiety. In rodents, testosterone (T) exerts anxiolytic effects via the androgen receptor (AR): we found that male mice with a naturally-occurring mutation rendering the AR dysfunctional, referred to as spontaneous testicular feminization mutation (_s_Tfm), showed more anxiety-like behaviors than wildtype (WT) males. Here, we used Cre–lox recombination technology to create another dysfunctional allele for AR. These induced Tfm (_i_Tfm) animals also displayed more anxiety-like behaviors than WTs. We further found that AR-modulation of these behaviors interacts with circadian phase. When tested in the resting phase, _i_Tfms appeared more anxious than WTs in the open field, novel object and elevated plus maze tests, but not the light/dark box. However, when tested during the active phase (lights off), _i_Tfms showed more anxiety-related behavior than WTs in all four tests. Finally, we confirmed a role of T acting via AR in regulating HPA axis activity, as WT males with T showed a lower baseline and overall corticosterone response, and a faster return to baseline following mild stress than did WT males without T or _i_Tfms. These findings demonstrate that this recombined AR allele is a valuable model for studying androgenic modulation of anxiety, that the anxiolytic effects of AR in mice are more prominent in the active phase, and that HPA axis modulation by T is AR dependent.
Highlights
- Testosterone (T) acts through androgen receptors (AR) to produce anxiolytic effects.
- Photoperiod interacts with AR's capacity to modulate some anxiety-related behavior.
- T acting through AR lowers baseline corticosterone (CORT) levels.
- T acts through AR to hasten HPA return to baseline levels after mild stress.
- Cre–lox recombination of AR allele disrupts testosterone's anxiolytic effects.